On-Demand Catalog

All sessions average between 60 and 90 minutes.

Animal Drug Compounding: FDA’s New Guidance and Impacts on Industry
COVID-19 and Beyond: Development and Implementation of Recovery Action Plans for Medical Product Manufacturers
The Long-Awaited Biologics Transition Date Has Come: What Now?
FDA’s Recent COVID-19 Guidances Facilitating Expanded Access to Certain Medical Products
COVID-19 and Beyond: Crisis Preparation, Management, and Recovery in the Food and Dietary Supplement Industries
What are FDA’s Tools for Responding to Public Health Emergencies Such as the Coronavirus (COVID-19)?
FDA-Related Congressional Committees: Jurisdiction, Focus, and Roles
Nicotine: What it Is, What it Does, and How to Effectively Communicate this Information to the Public
The CREATES Act Has Passed: What Does It Mean for the Generics Industry?
The USDA Hemp Interim Final Rule: Status, Remaining Issues, and Next Steps

Filter Results